Belite Bio (BLTE) Change in Accured Expenses (2020 - 2025)
Belite Bio (BLTE) posted quarterly Change in Accured Expenses of $1.8 million for Q4 2025, down 36.71% year-over-year from $2.9 million in Q4 2024, and down 36.71% quarter-over-quarter from $2.9 million in Q4 2024.
Powered by 
Analysis
Belite Bio (BLTE) Change in Accured Expenses (2020 - 2025) Analysis & Trends
Belite Bio's Change in Accured Expenses history runs 2 years deep, the most recent figure standing at $1.8 million for Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 11.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | 55.78 Mn |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 212.44 Mn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 61.62 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 68.82 Mn |
| 10 | Belite Bio | 6.26 Bn | 6.26 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.84 Mn |
| Dec 31, 2024 | 2.91 Mn |
| Dec 31, 2020 | -254,000.00 |